Form 4: Hims & Hers Director Granted RSUs

Hims & Hers Director Christiane Pendarvis receives 3,656 RSU grant.

Summary

• Christiane Pendarvis, a Director of Hims & Hers Health, Inc. (HIMS), was granted 3,656 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of Class A Common Stock.
• The RSUs were granted on August 6, 2025, with a price of $0.
• Vesting is contingent on continuous service and will occur on the earlier of the 2026 annual meeting of stockholders or June 15, 2026.
• Following this transaction, Ms. Pendarvis beneficially owns 3,656 RSUs directly.

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units to a director is a routine compensation event that aligns the director's interests with long-term shareholder value, indicating stability in governance.

Positives

• The grant of 3,656 Restricted Stock Units to a Director aligns their interests with long-term shareholder value.

Future Outlook

The granted Restricted Stock Units are expected to vest on the earlier of the 2026 annual meeting of stockholders or June 15, 2026, subject to continuous service.

Industry Context

The grant of Restricted Stock Units to directors is a common practice in the healthcare and technology sectors to incentivize long-term commitment and align executive interests with shareholder returns. This type of equity compensation is standard across publicly traded companies.

Comparison to Industry Standards

• Equity grants, specifically RSUs, are a standard component of director compensation packages across the healthcare and telehealth industries, including peers like Teladoc Health (TDOC) and GoodRx (GDRX), aiming to align long-term incentives.
• The $0 grant price is typical for RSU awards, reflecting their nature as a contingent right to receive shares upon vesting, rather than a purchase.

Related Party Transactions

• Grant of 3,656 Restricted Stock Units to Christiane Pendarvis, a Director of Hims & Hers Health, Inc., as part of her compensation.

Stakeholder Impact

• Shareholders: Interests of the director are further aligned with shareholders through equity ownership.

Next Steps

• Vesting of 3,656 Restricted Stock Units on the earlier of the 2026 annual meeting of stockholders or June 15, 2026.

Key Dates

Recommendation

This Form 4 filing details a routine Restricted Stock Unit grant to a director, which is a standard compensation practice and does not provide new material information to warrant a change in investment recommendation. It primarily serves to align director incentives with long-term shareholder value.

Keywords

Hims & Hers, HIMS, Restricted Stock Units, RSU, Director Compensation, SEC Form 4, Insider Transaction, Equity Grant